Current Promotions

No active promotions at the moment. Check back later for special offers!

No video available

Get in Touch

Call Now Visit Website

About

Leaders of the Global Liquid Biopsy Revolution

As pioneers in blood-based cell-free tumor DNA (ctDNA) mutation detection, Sysmex Inostics has provided custom assays and CLIA-certified lab services to leading BioPharma companies over the last 10 years with the overall goal: to develop therapeutics that extend lives and provide diagnostics to monitor response to therapy, identify targetable resistance alterations, and detect minimal residual disease (MRD).

Plasma-Safe-SeQs NGS technology can detect clinically relevant mutations in circulating tumor DNA (ctDNA) with robust detection as low as 0.03% mutant allele frequency (MAF), thus ensuring reliable molecular information for real-time therapy selection as well as monitoring of tumor response from across a broader range of genomic regions.

Keywords

mutation detection, sequence analysis, oncology, molecular diagnostics, circulating tumor dna, ctdna, plasma ngs, next generation sequencing, digital pcr, beaming, clinical trials, ngs, clia, gcp, cancer, molecular testing, medicine, research, ivd kit, plasmasafeseqs, liquid biopsy, cfdna, cell free dna, cfhpvdna, lbx

Amenities

No amenities listed yet

Upcoming Events

No upcoming events scheduled

Frequently Asked Questions

No FAQs available for this business.

Reviews

No reviews yet. Be the first to review!

Social Links

Photo Gallery

No photos available

Business Info

82
2008
$12.5M

Business Hours

Business hours not available

Own This Business?

Unclaimed

Take control of your business page to update information, respond to reviews, and more.

Claim This Business